DefinitionThis section has been translated automatically.
- Group of predominantly antilysosomal autoantibodies (mostly IgG), which are primarily detected using indirect immunofluorescence techniques. Three different fluorescence patterns are observed, which leads to the classification into three subtypes: cANCA (classical ANCA), pANCA (perinuclear ANCA), atypical ANCA (aANCA or xANCA) (see Table 1).
- Occurrence in vasculitis, chronic inflammatory rheumatic syndromes, chronic liver and intestinal diseases and infections. ANCA-associated vasculitides include Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis.
General informationThis section has been translated automatically.
You might also be interested in
DiagnosisThis section has been translated automatically.
LiteratureThis section has been translated automatically.
- Day CJ et al (2003) New developments in the pathogenesis of ANCA-associated vasculitis. Clin Exp Rheumatol 21(6 Suppl 32): S35-48
- Gross WL et al (1995) ANCA-associated vasculitis. Dermatologist 46: 511-524
- Kallenberg CG et al (2002) New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmune Rev 1: 61-66
- Keogh KA et al (2003) Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. On J Med 115: 284-290
TablesThis section has been translated automatically.
ANCA subtypes, target antigens and associated diseases (according to Gross WL and Schmitt WH)
Acronym |
Target antigen(s) |
Associated diseases |
cANCA |
Proteinase 3 = PR3 |
Wegener's granulomatosis; more rarely in microscopic polyangiitis, Churg-Strauss syndrome and amoeba-induced liver abscess |
pANCA |
myeloperoxidase (MPO) |
Microscopic polyangiitis, renal vasculitis (idiopathic rapid-progressive GN) |
lactoferrin, cathepsin G, elastase, lysozyme |
Inflammatory rheumatic diseases like rheumatoid arthritis and vasculitis, SLE, Sjögren's syndrome |
|
a/pANCA |
BPIa (= CAP57)? |
Ulcerative colitis, primary sclerosing cholangitis, 10-20% Crohn's disease |
ANCA in vasculitis, collagenosis and other rheumatic diseases (according to Gross WL and Schmitt WH)
Entity |
CANCA [%] |
pANCA [%] |
Target antigen(s) |
|
Vasculitides |
Wegener's granulomatosis (initial phase) |
50 |
< 5 |
PR3a |
Wegener's granulomatosis (generalisation) |
90 |
< 5 |
PR3a |
|
Churg-Strauss Syndrome |
20 |
20 |
PR3, MPOa |
|
Microscopic polyangiitis |
10 |
60 |
||
Purpura Beauty Enoch |
- |
< 5 |
||
cryoglobulinemic vasculitis |
- |
- |
||
Leucocytoclastic vasculitis |
- |
- |
||
polyarteritis nodosa |
< 5 |
< 5 |
||
Kawasaki's Arteritis |
- |
- |
||
Giant Cell Arteritis |
- |
5 |
||
Takayasu arteritis |
- |
- |
||
| ||||
Collagenoses and related inflammatory rheumatic diseases |
SLE |
- |
25 |
LF, HLE, LZb |
Sjögren's Syndrome |
- |
25 |
LF, HLE, CG, LZb |
|
Polymyositis |
- |
< 10 |
||
Rheumatoid Arthritis |
- |
20 |
LF, HLE, CG, LZb |
|
rheumatoid vasculitis |
- |
50 |
LF, HLE, CG, LZb |
|
Felty Syndrome |
- |
50 |
LF, HLE, CG, LZb |
|
Spondylarthritides |
- |
< 10 |